BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8896070)

  • 1. Immunogenetic studies of Behçet's disease.
    Mizuki N; Ohno S
    Rev Rhum Engl Ed; 1996; 63(7-8):520-7. PubMed ID: 8896070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic gene responsible for the predisposition of Behçet's disease.
    Mizuki N; Inoko H; Ohno S
    Int Rev Immunol; 1997; 14(1):33-48. PubMed ID: 9203025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Goto K; Nakamura S; Bahram S; Ohno S; Inoko H
    Arthritis Rheum; 1999 Sep; 42(9):1961-6. PubMed ID: 10513813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics (HLA) of Behçet's disease.
    Mizuki N; Inoko H; Ohno S
    Yonsei Med J; 1997 Dec; 38(6):333-49. PubMed ID: 9509902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease.
    Mizuki N; Inoko H; Sugimura K; Nishimura K; Nakamura S; Tanaka H; Mizuki N; Mizuki H; Inaba G; Tsuji K
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3084-90. PubMed ID: 1356945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations.
    Mizuki N; Ota M; Yabuki K; Katsuyama Y; Ando H; Palimeris GD; Kaklamani E; Accorinti M; Pivetti-Pezzi P; Ohno S; Inoko H
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3702-8. PubMed ID: 11053265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
    Cohen R; Metzger S; Nahir M; Chajek-Shaul T
    Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece.
    Yabuki K; Mizuki N; Ota M; Katsuyama Y; Palimeris G; Stavropoulos C; Koumantaki Y; Spyropoulou M; Giziaki E; Kaklamani V; Kaklamani E; Inoko H; Ohno S
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1921-6. PubMed ID: 10440244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent findings on the genetics of Behçet's disease].
    Hüe-Lemoine S; Amoura Z; Wechsler B; Piette JC; Caillat-Zucman S
    Ann Med Interne (Paris); 1999 Oct; 150(6):499-503. PubMed ID: 10615536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
    Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behçet's disease.
    Chang HK; Jang WC; Park SB; Nam YH; Lee SS; Park YW; Kim SK
    Scand J Rheumatol; 2007; 36(3):216-21. PubMed ID: 17657677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.
    Mizuki N; Inoko H; Mizuki N; Tanaka H; Kera J; Tsuiji K; Ohno S
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3332-40. PubMed ID: 1358857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-C genotyping of patient with Behçet's disease in the Japanese population.
    Mizuki N; Ohno S; Ando H; Kimura M; Ishihara M; Miyata S; Nakamura S; Mizuki N; Inoko H
    Hum Immunol; 1996 Sep; 50(1):47-53. PubMed ID: 8872174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease.
    Takemoto Y; Naruse T; Namba K; Kitaichi N; Ota M; Shindo Y; Mizuki N; Gul A; Madanat W; Chams H; Davatchi F; Inoko H; Ohno S; Kimura A
    Tissue Antigens; 2008 Oct; 72(4):347-53. PubMed ID: 18700875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease.
    Mizuki N; Ohno S; Sato T; Ishihara M; Miyata S; Nakamura S; Naruse T; Mizuki H; Tsuji K; Inoko H
    Hum Immunol; 1995 Jun; 43(2):129-35. PubMed ID: 7591872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspective on Behçet's disease.
    Sakane T
    Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pathogenesis and therapy of Behçet's disease.
    Arayssi T; Hamdan A
    Curr Opin Pharmacol; 2004 Apr; 4(2):183-8. PubMed ID: 15063364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
    Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
    Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.